Morphine, Quantitative, Urine
Also known as: Kadian®, MS Contin®, Roxanol®
Use
Detect presence of morphine, an opiate analgesic and heroin metabolite
Special Instructions
Urine samples must be collected in a clean container, and it is important to follow proper patient identification and labeling procedures to ensure the sample is not compromised. Patients should be advised to avoid taking any medications that might interfere with the test results prior to sample collection.
Limitations
This test is specific for morphine and may not detect other opioids that the patient may be using. False positives or negatives can occur if the specimen is subject to contamination or if the patient has consumed other substances that interact with morphine. Pharmacokinetic variations between individuals can also affect test outcomes, and it is important to consider the patient's overall pharmacological profile when interpreting results.
Methodology
Mass Spectrometry
Biomarkers
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
30 mL
Minimum Volume
10 mL
Container
Clean container
Collection Instructions
Collect urine in a clean container following proper labeling and identification protocols.
Patient Preparation
Avoid consuming medications that may interfere with the test for a defined period before sample collection.
Storage Instructions
Refrigerate the sample if not analyzed immediately to preserve integrity.
Causes for Rejection
Improper labeling, contaminated samples, and inadequate volume.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 7 days |
| Frozen | 30 days |